7 Day Trial
ALL ACCESS PASS
10K form not available
Receive TXG News And Ratings
See the #1 stock for the next 7 days that we like better than TXG
TXG Financial Statistics
Sales & Book Value
|Price / Cash Flow:||0|
|Price / Book:||6.69|
|Net Income (TTM):||$-223.36M|
|Return on Equity:||-28.47%|
|Return on Assets:||-22.44%|
10x Genomics Earnings Forecast
Key 10x Genomics Financial Ratios
- The Gross Profit Margin over the past 6 years for TXG is 76.69%.
- The Selling, General & Administrative Expenses for TXG have been equal to 57.76% of Gross Profit Margin.
- The Research & Development expenses have been 51.45% of Revenue.
- The Interest Expense is -0.29% of Operating Income.
- The Net Earning history of TXG is -32.15% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
10x Genomics Stock Price Chart
Industry, Sector and Symbol
|Industry:||Health Information Services|
|Trailing P/E Ratio:||0|
|Forward P/E Ratio:||129.72|